On top of this wonderful healthcare business, Abbott, like Coca-Cola, has made rewarding shareholders part of its strategy.

These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.

According to Precedence Research, the global glucose biosensors market size will grow from USD 10.71 billion in 2025 to nearly USD 23.08 billion by 2034, with an expected CAGR of 8.91% from 2025 to ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device – which is ...

A review of 17 studies reports a fourfold increase in risk and ties worse hearing to longer disease duration and higher HbA1c ...

Former UK Prime Minister Theresa May recounted her own experience of being diagnosed with diabetes while addressing Malta's parliament on Saturday, urging lawmakers to improve public understanding of ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the ...

From Diwali's lights in India to a "spiffy-drop" on Netflix, this Mailbag travels widely and thinks deeply. A listener celebrates the Rule Breaker habit of lighting candles, not fanning flames, while ...

Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...

Joining the American Association of Retired Persons (AARP) might be the best bang for your buck in retirement. Memberships ...

Insulet Corporation PODD reported third-quarter 2025 adjusted earnings per share (EPS) of $1.24, up 37.8% from the year-ago ...

Managing diabetes isn’t about perfection—it’s about progress. Every small action adds up: 1- Choosing water over soda. 2- Walking 20 minutes after dinner. 3- Checking your glucose once more this week.